Skip to main content
Clinical Trials/KCT0005098
KCT0005098
Completed
N/A

Pilot study of focused ultrasound stimulator system(NS-US100) to evaluate efficacy and safety of BBB (Blood-Brain Barrier) disruption for Alzheimer's disease patients

The Catholic University of Korea, Incheon St. Mary's Hospital0 sites15 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
The Catholic University of Korea, Incheon St. Mary's Hospital
Enrollment
15
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 18, 2021
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
The Catholic University of Korea, Incheon St. Mary's Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults between 65 and 85 years of age
  • 2\. Those who were diagnosed with probable Alzheimer's disease according to the Neurological and Communicative Disorders and Stroke\-Alzheimer’s Disease and Related Disorders Association (NINCDS\-ADRDA) and meet the criteria for dementia according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM\-IV)
  • 3\. Patients with a clinical dementia rating (CDR) 1\-3 and MMSE less than 20 to exclude mild cognitive impairment and early Alzheimer's disease

Exclusion Criteria

  • 1\. Presence of underlying lesions in the brain (eg, cerebral hemorrhage, cerebral infarction, cerebrovascular malformation, brain tumor, etc.) on magnetic resonance imaging (MRI)
  • 2\. Taking drugs that may cause cognitive impairment (eg, anticholinergic drugs)
  • 3\. History of epileptic seizure, presence of depression or psychiatric symptoms, visual hallucination, and cognitive decline
  • 4\. History of psychiatric disorders other than what is specified in inclusion criteria
  • 5\. Those who have major medical illnesses such as cancer / tuberculosis
  • 6\. Those with difficulties to accurately evaluate cognitive function due to the drug being administered
  • 7\. Those who have contact dermatitis or problems related to sensitive skin
  • 8\. Those not suitable for MRI
  • 9\. Pregnancy
  • 10\. Calcification in the brain on computed tomography (CT)

Outcomes

Primary Outcomes

Not specified

Similar Trials